Meaghan Broman

Dr. Meaghan Broman

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
MBMeaghan Broman
Meaghan Broman
NLNadia Atallah Lanman
Nadia Atallah Lanman
RVRenee E. Vickman
Renee E. Vickman
GCGregory M. Cresswell
Gregory M. Cresswell
HKHarish Kothandaraman
Harish Kothandaraman
TRTimothy L. Ratliff
Timothy L. Ratliff
Benign prostatic hyperplasia (BPH) is among the most common age-associated diseases in men; however, the contribution of age-related changes in immune cells to BPH is not clear. The current study determined that an age-associated CD8 + T cell subset (Taa) with high Granzyme K ( GZMK hi ) and low Granzyme B ( GZMB low ) gene expression infiltrate aged human prostates and positively correlate with International Prostate Symptom Score (IPSS). A velocity analysis indicated that CD8 + T cell differentiation is altered in large BPH prostates compared to small age-matched prostates, favoring Taa accumulation. In vitro granzyme K treatment of human BPH patient-derived large prostate fibroblasts increased secretion of pro-inflammatory senescence-associated secretory phenotype (SASP)-associated cytokines. These data suggest that granzyme K-mediated stimulation of prostate stromal fibroblast SASP cytokine and chemokine production promotes prostate immune cell recruitment and activation. Overall, these results connect symptomatic BPH with immune aging.

24 May 2025 in Cancers
Verified
Journal Article
Open access
PDF file
SHSamrin F. Habbani
Samrin F. Habbani
Sayeh DowlatshahiSayeh Dowlatshahi
Sayeh Dowlatshahi
NLNathanael Lichti
Nathanael Lichti
MBMeaghan Broman
Meaghan Broman
LTLucy Tecle
Lucy Tecle
Sulma I. MohammedSulma I. Mohammed
Sulma I. Mohammed
Background/Objectives: Cervical cancer (CC) is a significant global health challenge, particularly in low- and middle-income countries (LMICs), where limited access to human papillomavirus (HPV) vaccination and effective CC screening results in a majority of cases and fatalities among women. Moreover, existing vaccines do not target HPV-independent cancers. Current screening methods are expensive and time-consuming, with a limited emphasis on CC protein biomarkers. Therefore, we aimed to validate critical markers that allow the development of affordable point-of-care screening tests for resource-limited settings. Methods: This study first optimized a cell lysis and protein extraction protocol for CC cell lines and clinical cervical swabs. Subsequently, four proteins—topoisomerase II alpha (TOP2A), minichromosome maintenance complex component 2 (MCM2), valosin-containing protein (VCP), and cyclin-dependent kinase inhibitor 2A (p16INK4a)—were quantified in the resulting lysates using enzyme-linked immunosorbent assays, as well as in cervical tumors and squamous intraepithelial lesions (SILs) using immunohistochemistry for further validation. Results: Acetone precipitation allowed for efficient cell isolation, and radioimmunoprecipitation assay buffer yielded the highest protein recovery. VCP and p16INK4a were overexpressed across all cancer cell lines compared to primary cells. All four biomarkers were overexpressed in high-grade SIL (HSIL) swab specimens and tumor samples, including CC subtypes, G1–G3 tumor grades, and HSILs. Lastly, we showed that the proteins could accurately classify swabs and tissue specimens into clinically relevant groups. Conclusions: The quantitative analysis of these biomarkers, along with the subsequent sensitive and specific clinical classification, highlights their potential application in SIL early detection and CC prevention, particularly in LMICs.

1 June 2016 in Journal of the American Veterinary Medical Association
Verified
Journal Article
Closed access
MBMeaghan Broman
Meaghan Broman
MMMargaret A. Miller
Margaret A. Miller

9 February 2018 in Acta Veterinaria Scandinavica
Verified
Journal Article
Open access
PDF file
HHHock Gan Heng
Hock Gan Heng
CLChee Kin Lim
Chee Kin Lim
SSSarah Steinbach
Sarah Steinbach
MBMeaghan Broman
Meaghan Broman
MMMargaret Allan Miller
Margaret Allan Miller
Ultrasonographic appearance of unorganized hyperechoic striations (UHS) has been observed in the canine gastric muscularis layer. The purpose of the study was to determine the prevalence, sonographic and postmortem histologic features, and to determine the clinical significance of canine gastric muscularis UHS. In the prospective study, 72 dogs were included. The presence of gastric muscularis UHS were reviewed to determine its distribution and location. In the retrospective study, 167 dogs that had both abdominal ultrasonography and necropsy were included. The prevalence of gastric muscularis UHS in dogs was 37.5% in the prospective and 5.4% in the retrospective studies respectively. The higher prevalence in prospective study was due to greater anticipation by the radiologists in search for gastric muscularis UHS. In the ventral gastric wall, the muscularis UHS were better defined when the gastric lumen was empty or non-distended, and were mostly parallel with the serosa when the gastric wall was distended (with gas or fluid). Visualization of the dorsal gastric wall was often obscured by gas shadowing from luminal gas. Histopathology was performed on eight dogs with gastric muscularis UHS, three of which had fibrous tissue observed with Masson’s trichrome stain. Presence of gastric muscularis UHS in dogs may have been attributable to presence of incomplete interfaces between the inner oblique, middle circular and outer longitudinal layers of the gastric tunica muscularis or due to presence of fibrous tissue within the gastric muscularis layer. The clinical significance of canine gastric muscularis UHS is uncertain.

22 June 2026
Verified
Other
Open access
YHYanying He
Yanying He
JZJiaqi Zhao
Jiaqi Zhao
JKJung Suk Kim
Jung Suk Kim
MBMeaghan Broman
Meaghan Broman
SBSimone de Brot
Simone de Brot
YYYoon Yeo
Yoon Yeo
Locally injected IMAX is retained at the injection site with minimal systemic absorption. PTX levels (μg/g) in skin (or tumor) and (ng/mL) in plasma at 6, 24, and 48 hours after subcutaneous or intratumoral injection of IMAX (containing 1 mg 2E′) in healthy and CT26 tumor-bearing BALB/c mice (7–8 weeks). n = 4 mice per time point. Data are the mean ± SD. P value was calculated by Sidak multiple comparisons test, following two-way ANOVA.

22 June 2026
Verified
Other
Open access
YHYanying He
Yanying He
JZJiaqi Zhao
Jiaqi Zhao
JKJung Suk Kim
Jung Suk Kim
MBMeaghan Broman
Meaghan Broman
SBSimone de Brot
Simone de Brot
YYYoon Yeo
Yoon Yeo
RNA-seq of companion dog tumor biopsies before and after IMAX treatment. A, Heatmaps of differentially expressed genes in cGAS/STING pathway, TLR pathway, and NFkB pathway. Data were scaled from positive to negative gene expression values to evaluate trends before and after IMAX treatment. B, A z-scaled heatmap of the ssGSEA scores for gene sets in specific biological pathways. The color scale indicates z-scaled ssGSEA scores across samples. Dog RV: PRE (before treatment), 2D (2 days after the second treatment), and 2W (2 weeks after the third treatment, two locations from the same mass). Dog CL: PRE (before treatment, two locations, cranial and caudal masses), 1W (1 week after the second treatment, two locations), and 1M (1 month after the second treatment, two locations). Dog BM: PRE (before treatment), 1W (1 week after the second treatment), and 3W (3 weeks after the second treatment). EMT, epithelial–mesenchymal transition; KEGG, Kyoto Encyclopedia of Genes and Genomes; TCR, T-cell receptor; Treg, regulatory T cell.